757 related articles for article (PubMed ID: 32442232)
41. Oral Agents for the Treatment of Gestational Diabetes.
Finneran MM; Landon MB
Curr Diab Rep; 2018 Sep; 18(11):119. PubMed ID: 30267230
[TBL] [Abstract][Full Text] [Related]
42. Neonatal adiposity following maternal treatment of gestational diabetes with glyburide compared with insulin.
Lain KY; Garabedian MJ; Daftary A; Jeyabalan A
Am J Obstet Gynecol; 2009 May; 200(5):501.e1-6. PubMed ID: 19375570
[TBL] [Abstract][Full Text] [Related]
43. Therapeutic management, delivery, and postpartum risk assessment and screening in gestational diabetes.
Nicholson WK; Wilson LM; Witkop CT; Baptiste-Roberts K; Bennett WL; Bolen S; Barone BB; Golden SH; Gary TL; Neale DM; Bass EB
Evid Rep Technol Assess (Full Rep); 2008 Mar; (162):1-96. PubMed ID: 18457474
[TBL] [Abstract][Full Text] [Related]
44. A meta-analysis of metformin and insulin on maternal outcome and neonatal outcome in patients with gestational diabetes mellitus.
Wu R; Zhang Q; Li Z
J Matern Fetal Neonatal Med; 2024 Dec; 37(1):2295809. PubMed ID: 38124287
[TBL] [Abstract][Full Text] [Related]
45. Examining the Starting Dose of Glyburide in Gestational Diabetes.
Glover AV; Tita A; Biggio JR; Harper LM
Am J Perinatol; 2016 Jan; 33(2):214-20. PubMed ID: 26368915
[TBL] [Abstract][Full Text] [Related]
46. Perinatal outcomes and the use of oral hypoglycemic agents.
Bertini AM; Silva JC; Taborda W; Becker F; Lemos Bebber FR; Zucco Viesi JM; Aquim G; Engel Ribeiro T
J Perinat Med; 2005; 33(6):519-23. PubMed ID: 16318615
[TBL] [Abstract][Full Text] [Related]
47. The Use of Non-insulin Agents in Gestational Diabetes: Clinical Considerations in Tailoring Therapy.
Blair RA; Rosenberg EA; Palermo NE
Curr Diab Rep; 2019 Dec; 19(12):158. PubMed ID: 31811400
[TBL] [Abstract][Full Text] [Related]
48. Glyburide Versus Metformin and Their Combination for the Treatment of Gestational Diabetes Mellitus: A Randomized Controlled Study.
Nachum Z; Zafran N; Salim R; Hissin N; Hasanein J; Gam Ze Letova Y; Suleiman A; Yefet E
Diabetes Care; 2017 Mar; 40(3):332-337. PubMed ID: 28077460
[TBL] [Abstract][Full Text] [Related]
49. Association of Adverse Pregnancy Outcomes With Glyburide vs Insulin in Women With Gestational Diabetes.
Camelo Castillo W; Boggess K; Stürmer T; Brookhart MA; Benjamin DK; Jonsson Funk M
JAMA Pediatr; 2015 May; 169(5):452-8. PubMed ID: 25822253
[TBL] [Abstract][Full Text] [Related]
50. Non-insulin pharmacological therapy in pregnancy.
Bajaj S
J Pak Med Assoc; 2016 Sep; 66(9 Suppl 1):S45-7. PubMed ID: 27582151
[TBL] [Abstract][Full Text] [Related]
51. Glyburide therapy for gestational diabetes: Glycaemic control, maternal hypoglycaemia, and treatment failure.
Affres H; Senat MV; Letourneau A; Deruelle P; Coustols-Valat M; Bouchghoul H; Bouyer J
Diabetes Metab; 2021 Jul; 47(4):101210. PubMed ID: 33249198
[TBL] [Abstract][Full Text] [Related]
52. A cautionary response to SMFM statement: pharmacological treatment of gestational diabetes.
Barbour LA; Scifres C; Valent AM; Friedman JE; Buchanan TA; Coustan D; Aagaard K; Thornburg KL; Catalano PM; Galan HL; Hay WW; Frias AE; Shankar K; Simmons RA; Moses RG; Sacks DA; Loeken MR
Am J Obstet Gynecol; 2018 Oct; 219(4):367.e1-367.e7. PubMed ID: 29959933
[TBL] [Abstract][Full Text] [Related]
53. Systematic review of the use of metformin compared to insulin for the management of gestational diabetes: Implications for low-resource settings.
Kattini R; Kelly L; Hummelen R
Can J Rural Med; 2023; 28(2):59-65. PubMed ID: 37005989
[TBL] [Abstract][Full Text] [Related]
54. A comparison of glyburide and insulin in women with gestational diabetes mellitus.
Langer O; Conway DL; Berkus MD; Xenakis EM; Gonzales O
N Engl J Med; 2000 Oct; 343(16):1134-8. PubMed ID: 11036118
[TBL] [Abstract][Full Text] [Related]
55. Gestational diabetes mellitus management with oral hypoglycemic agents.
Ryu RJ; Hays KE; Hebert MF
Semin Perinatol; 2014 Dec; 38(8):508-15. PubMed ID: 25315294
[TBL] [Abstract][Full Text] [Related]
56. Effectiveness of antidiabetic agents for treatment of gestational diabetes: A methodological quality assessment of meta-analyses and network meta-analysis.
Bidhendi Yarandi R; Amiri M; Ramezani Tehrani F; Behboudi-Gandevani S
J Diabetes Investig; 2021 Dec; 12(12):2247-2258. PubMed ID: 34042261
[TBL] [Abstract][Full Text] [Related]
57. Diagnosis and new approaches in the therapy of gestational diabetes mellitus.
Schaefer-Graf UM; Kleinwechter H
Curr Diabetes Rev; 2006 Aug; 2(3):343-52. PubMed ID: 18220639
[TBL] [Abstract][Full Text] [Related]
58. Association of Long-term Child Growth and Developmental Outcomes With Metformin vs Insulin Treatment for Gestational Diabetes.
Landi SN; Radke S; Engel SM; Boggess K; Stürmer T; Howe AS; Funk MJ
JAMA Pediatr; 2019 Feb; 173(2):160-168. PubMed ID: 30508164
[TBL] [Abstract][Full Text] [Related]
59. Metformin versus Placebo in Obese Pregnant Women without Diabetes Mellitus.
Syngelaki A; Nicolaides KH; Balani J; Hyer S; Akolekar R; Kotecha R; Pastides A; Shehata H
N Engl J Med; 2016 Feb; 374(5):434-43. PubMed ID: 26840133
[TBL] [Abstract][Full Text] [Related]
60. HbA1c and Gestational Weight Gain Are Factors that Influence Neonatal Outcome in Mothers with Gestational Diabetes.
Barquiel B; Herranz L; Hillman N; Burgos MÁ; Grande C; Tukia KM; Bartha JL; Pallardo LF
J Womens Health (Larchmt); 2016 Jun; 25(6):579-85. PubMed ID: 26918922
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
